pharma · Alagille Syndrome · Progressive Familial Intrahepatic Cholestasis (PFIC) · MIRM
Mirum Pharmaceuticals International
Mirum Pharmaceuticals International B.V.
Mirum Pharmaceuticals International trial registry — 34 ClinicalTrials.gov studies with program phase, status, and indication context.
989 E Hillsdale Blvd., Suite 300, Foster City, CA 94404, US HQ
2018 Founded
436 Employees
Public company Type
MIRM · NYSE Ticker
Company details
- Status
- Public
- HQ
- 989 E Hillsdale Blvd., Suite 300, Foster City, CA 94404, US
- Founded
- 2018
- Employees
- 436
- Programs
- 25
- Drugs
- 10
- Patents
- 4
Mirum Pharmaceuticals International clinical trials
Registry index of 34 ClinicalTrials.gov studies linked to Mirum Pharmaceuticals International programs — each row shows trial ID, program name, phase, status, and indication.
Mirum Pharmaceuticals International trial registry — 34 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Mirum Pharmaceuticals International.
-
Maralixibat — Phase 3
Clinical update -
Maralixibat — Phase 2
Clinical update -
Maralixibat — Phase 2
Clinical update -
Maralixibat — Phase 3
Clinical update -
Maralixibat — Phase 2
Clinical update -
Maralixibat — Phase 2
Clinical update -
LUM001 (Maralixibat) — Phase 2
Clinical update -
Low dose of MRM-3379 — Phase 2
Clinical update
Trial registry
-
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗